Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2013; 19(43): 7671-7679
Published online Nov 21, 2013. doi: 10.3748/wjg.v19.i43.7671
Published online Nov 21, 2013. doi: 10.3748/wjg.v19.i43.7671
Figure 1 Flow diagram of study participants.
LMA: Lamivudine; ADV: Adefovir; LdT: Telbivudine; HBV: High hepatitis B virus; HBeAg: Hepatitis Be antigen.
- Citation: Park H, Park JY, Kim SU, Kim DY, Han KH, Chon CY, Ahn SH. Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir. World J Gastroenterol 2013; 19(43): 7671-7679
- URL: https://www.wjgnet.com/1007-9327/full/v19/i43/7671.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i43.7671